$AMRN Recent Headlines Dow industrials suffer worst drop

New Post Public Reply Private Reply Replies (0) Message Board

Jan 14, 2014 at 11:02 AM

$AMRN Recent Headlines

Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 6:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 6:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 7:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 4:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 8:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 7:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 11:29 a.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 11:06 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 9:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 11:12 a.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 11:45 a.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 9:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 5:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 4:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 2:13 p.m. July 26, 2012 - Val Brickates Kennedy
Amarin halted ahead of FDA decision deadline 2:04 p.m. July 26, 2012 - Val Brickates Kennedy

Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends 9:06 a.m. Jan. 13, 2014 - Seeking Alpha
Amarin Out, Intercept Pharma In At J.P. Morgan Healthcare Confab 11:35 a.m. Jan. 12, 2014 - TheStreet.com
While Amarin Continues To Go Rancid, Neptune Will Soar 8:34 a.m. Jan. 11, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Small Cap BioPharmas With Near Term Catalysts 7:55 a.m. Jan. 3, 2014 - Seeking Alpha
AMRN January 10th Options Begin Trading 11:43 a.m. Jan. 2, 2014 - TheStreet.com
Chelsea: FDA Panel Meeting And Trading Strategies 4:34 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Amarin: 3 Things Shareholders Should Demand In 2014 12:13 a.m. Dec. 30, 2013 - Seeking Alpha
Update on Amarin's Vascepa - Analyst Blog 11:15 a.m. Dec. 27, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 2:45 a.m. Dec. 25, 2013 - InvestorPlace.com
4 Biotech Stocks on the Move 1:14 p.m. Dec. 20, 2013 - Wall St. Cheat Sheet
FDA Delays Decision on Amarin's Vascepa Drug 11:46 a.m. Dec. 20, 2013 - benzinga.com
Amarin's Anchor Gamble Sends Stock Up 20% On 'No News' News 11:18 a.m. Dec. 20, 2013 - Seeking Alpha
FDA delays ruling on expanding use of Amarin's Vascepa; shares soar 7:25 a.m. Dec. 20, 2013 - Seeking Alpha
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 5:03 a.m. Dec. 20, 2013 - benzinga.com
Amarin – Why AMRN Stock Is Set to Open to Sweet 24% Gains 3:12 a.m. Dec. 20, 2013 - InvestorPlace.com
Interesting AMRN Call Options For December 27th 11:24 a.m. Dec. 19, 2013 - TheStreet.com
Amarin's Vascepa: Too Limited A Market Or FDA Blunder? 1:11 p.m. Dec. 18, 2013 - benzinga.com

Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 8:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 8:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 3:29 p.m. Dec. 24, 2013 - PR Newswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Amarin Corporation plc of Upcoming Deadline 11:27 a.m. Dec. 20, 2013 - BusinessWire
Important Trend Analysis: Amarin Corporation plc, Corporation, Geron Corporation, 3D Systems Corporation 10:22 a.m. Dec. 20, 2013 - ACCESSWIRE
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 6:00 a.m. Dec. 20, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc Expanding the Class Period to Include July 9, 2009 Through October 16, 2013 and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Amarin Corporation plc to Inquire About the Lead Plaintiff Position Before the January 3, 2014 Lead Plaintiff Deadline -- AMRN 4:59 p.m. Dec. 19, 2013 - GlobeNewswire
Amarin Announces Leadership Changes 9:07 a.m. Dec. 16, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Files Class Action Lawsuit Against Amarin Corporation 9:32 p.m. Dec. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and a Lead Plaintiff Deadline of January 3, 2014 6:27 p.m. Dec. 11, 2013 - GlobeNewswire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations 6:00 a.m. Dec. 2, 2013 - GlobeNewswire
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Amarin Corporation plc 9:32 p.m. Nov. 27, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Amarin Corporation, plc and Certain Officers - AMRN 4:56 p.m. Nov. 27, 2013 - PR Newswire
Kantrowitz, Goldhamer & Graifman, P.C. Files Class Action Suit Against Amarin Corporation plc 3:44 p.m. Nov. 27, 2013 - BusinessWire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Bullish Stocks Commentary: Camtek Ltd, Lions Gate Entertainment, ImmunoCellular Therapeutics, Pandora Media, Amarin Corporation 8:47 a.m. Nov. 26, 2013 - PR Newswire
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Amarin Corporation plc 1:32 p.m. Nov. 22, 2013 - BusinessWire
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at EPR 10:19 a.m. Nov. 22, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...